Phase II randomized controlled trial of benfotiamine in early Alzheimer''s Disease Grant

Overview

date/time interval

July 15, 2022 -

awarded by

National Institute of Biomedical Imaging & Bioengineering

administered by

Neurology

sponsor award ID

1 R01 AG076634-01

Affiliation

contributor

Nordvig, Anna Starikovsky Principal Investigator (Subaward) 2022 - 2024